DNA damage and repair in human melanocytes: relation to melanomagenesis mutations
人类黑色素细胞的 DNA 损伤和修复:与黑色素瘤发生突变的关系
基本信息
- 批准号:9666114
- 负责人:
- 金额:$ 0.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-02-17 至 2017-07-31
- 项目状态:已结题
- 来源:
- 关键词:AKT1 geneAddressBRAF geneCDKN2A geneCatalogsCatalytic DomainCellsCutaneous MelanomaDNADNA DamageDNA RepairDNA Sequence AlterationDNA lesionDNA mappingDNA sequencingDataDevelopmentDiseaseEpidermisEtiologyEventFishesGenerationsGenesGenomeGenomic SegmentGoalsHumanLabelLesionMalignant NeoplasmsMapsMethodsMutagenesisMutateMutationNucleotidesPIK3CA genePTEN geneProcessPublic HealthPyrimidine DimersResolutionSeriesSiteSkinSomatic MutationSystemTP53 geneTechniquesTechnologyUV inducedUltraviolet Raysinsightinterestmelanocytemelanomamethylpurinenext generationnovelnovel strategiesoutcome predictionpreventrepaired
项目摘要
DESCRIPTION (provided by applicant): Cutaneous melanoma represents a significant and growing public health burden in the USA. This extremely deadly disease arises as a result of the acquisition of a series of genetic mutations in the melanocytes located in the bottom layer of the skin's epidermis. Although solar UV radiation is the primary cause of cutaneous melanoma, how UV causes the melanomagenesis mutations is poorly understood. Indeed, UV signature mutations, which are primarily caused by cyclobutane pyrimidine dimers (CPDs) directly induced by UV, are common in some mutated genes implicated in cutaneous melanoma. However, the UV signature mutations account for less than 10% of all melanomagenesis mutations. Therefore, DNA lesions indirectly induced by UV, such as the varieties of oxidative lesions and N-methylpurines (NMPs), and/or those induced by other as-yet-unidentified DNA damaging agents may be responsible for the majority of the melanomagenesis mutations. Our long term goal is to gain a deeper understanding of the etiological causes of melanomagenesis mutations and how DNA damage and repair are implicated in the mutagenesis process. Systematic nucleotide-level mapping of induction and repair of diverse types of DNA lesions in human melanocytes can offer invaluable insights into the causes of the melanomagenesis mutations. The major roadblock to this task is that all currently available methods for DNA damage and repair mapping lack the resolution, sensitivity and/or throughput. This proposal contains two specific aims. In aim 1, we will develop a novel extremely sensitive method for high-throughput nucleotide-level mapping of DNA damage and repair in living human cells. The next- generation DNA sequencing technologies will be utilized for the development of the novel method. In aim 2, we will map DNA damage induction and repair related to melanomagenesis mutations in human melanocytes. The induction and repair of various types of DNA lesions, including CPDs, oxidative lesions and NMPs, will be mapped in melanocytes from people of different skin types. The genomic regions we plan to map include the sites of melanomagenesis mutations and their neighboring sequences. The correlations of the DNA damage induction and repair events with the site-specific melanomagenesis mutations will be systematically assessed. The tendencies of the identified lesions to form the site-specific mutations will be further confirmed by using a technique that can detect a single mutation among millions or billions of wild type DNA molecules.
描述(由申请方提供):皮肤黑色素瘤在美国是一个显著且不断增长的公共卫生负担。这种极其致命的疾病是由于位于皮肤表皮底层的黑素细胞中的一系列基因突变而引起的。虽然太阳紫外线辐射是皮肤黑色素瘤的主要原因,但紫外线如何引起黑色素瘤突变的了解甚少。事实上,主要由UV直接诱导的环丁烷嘧啶二聚体(CPD)引起的UV特征突变在涉及皮肤黑素瘤的一些突变基因中是常见的。然而,UV特征突变占所有黑色素瘤突变的不到10%。因此,由UV间接诱导的DNA损伤,如各种氧化损伤和N-甲基嘌呤(NMPs),和/或由其他尚未鉴定的DNA损伤剂诱导的DNA损伤可能是大多数黑素瘤突变的原因。我们的长期目标是更深入地了解黑色素瘤突变的病因,以及DNA损伤和修复如何参与诱变过程。 系统的核苷酸水平映射的诱导和修复的不同类型的DNA损伤在人类黑色素细胞可以提供宝贵的见解的原因,黑色素瘤突变。这一任务的主要障碍是,目前所有可用的DNA损伤和修复映射的方法缺乏分辨率,灵敏度和/或吞吐量。 这项建议有两个具体目标。在目标1中,我们将开发一种新的非常灵敏的方法,用于在活体人类细胞中进行DNA损伤和修复的高通量核苷酸水平作图。下一代DNA测序技术将用于开发新方法。在目标2中,我们将绘制人类黑素细胞中与黑素瘤发生突变相关的DNA损伤诱导和修复。各种类型的DNA损伤的诱导和修复,包括CPD,氧化损伤和NMP,将在来自不同皮肤类型的人的黑素细胞中进行映射。我们计划绘制的基因组区域包括黑色素瘤发生突变的位点及其邻近序列。将系统地评估DNA损伤诱导和修复事件与位点特异性黑色素瘤发生突变的相关性。通过使用可以在数百万或数十亿野生型DNA分子中检测单个突变的技术,将进一步证实所鉴定的病变形成位点特异性突变的趋势。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shisheng Li其他文献
Shisheng Li的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shisheng Li', 18)}}的其他基金
Implication of histone H4 LRS mutations in translesion synthesis and UV mutagenesis
组蛋白 H4 LRS 突变对跨损伤合成和 UV 诱变的影响
- 批准号:
10353127 - 财政年份:2021
- 资助金额:
$ 0.63万 - 项目类别:
Implication of histone H4 LRS mutations in translesion synthesis and UV mutagenesis
组蛋白 H4 LRS 突变对跨损伤合成和 UV 诱变的影响
- 批准号:
10532160 - 财政年份:2021
- 资助金额:
$ 0.63万 - 项目类别:
High-throughput high-resolution mapping of DNA damage and repair in human cells.
人类细胞 DNA 损伤和修复的高通量高分辨率绘图。
- 批准号:
8386014 - 财政年份:2012
- 资助金额:
$ 0.63万 - 项目类别:
DNA damage and repair in human melanocytes: relation to melanomagenesis mutations
人类黑色素细胞的 DNA 损伤和修复:与黑色素瘤发生突变的关系
- 批准号:
8232782 - 财政年份:2012
- 资助金额:
$ 0.63万 - 项目类别:
High-throughput high-resolution mapping of DNA damage and repair in human cells.
人类细胞 DNA 损伤和修复的高通量高分辨率绘图。
- 批准号:
8514607 - 财政年份:2012
- 资助金额:
$ 0.63万 - 项目类别:
Transcription Coupled DNA Repair in S. cerevisiae
酿酒酵母中的转录耦合 DNA 修复
- 批准号:
7234415 - 财政年份:2004
- 资助金额:
$ 0.63万 - 项目类别:
Transcription Coupled DNA Repair in S. cerevisiae
酿酒酵母中的转录耦合 DNA 修复
- 批准号:
6985490 - 财政年份:2004
- 资助金额:
$ 0.63万 - 项目类别:
Transcription Coupled DNA Repair in S. cerevisiae
酿酒酵母中的转录耦合 DNA 修复
- 批准号:
6931075 - 财政年份:2004
- 资助金额:
$ 0.63万 - 项目类别:
Transcription Coupled DNA Repair in S. cerevisiae
酿酒酵母中的转录耦合 DNA 修复
- 批准号:
7072791 - 财政年份:2004
- 资助金额:
$ 0.63万 - 项目类别:
Transcription Coupled DNA Repair in S. cerevisiae
酿酒酵母中的转录耦合 DNA 修复
- 批准号:
6820052 - 财政年份:2004
- 资助金额:
$ 0.63万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 0.63万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 0.63万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 0.63万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 0.63万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 0.63万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 0.63万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 0.63万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 0.63万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 0.63万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 0.63万 - 项目类别:
Research Grant